Headline »

SDBN September 22nd 2014 Town Hall With 52nd District Congressman Scott Peters

September 2, 2014 – 12:54 pm | Edit Post

The SDBN is very pleased to host a Town Hall event with 52nd District Congressman Scott Peters September 22nd where we’ll discuss issues important to local life scientists and professionals such as research funding and …

Read the full story »

SDBN Blog »

NIH/NSF Funded Start-Ups Highlighted at #BIO2014

June 26, 2014 – 6:13 am | Edit Post

Traditionally, BIO has been focused on bringing well-established biotech and pharma companies together.  This year, the organizers wanted to shake things up abit and allow NIH/NSF funded SBIR companies, some of which have zero revenue, to showcase their business and have an opportunity to talk with investors and C-level execs about their work and vision for the future.   This all occurred at the INNOVATION Zone in the Exhibitor Hall throughout the conference. There were more than 50 companies presenting with a focus on drug discovery, diagnostics, biofuels and many other platform technologies.

Image 1: Innovation Zone at @BioConvention Exhibitor Hall

Image 1: Innovation Zone at @BioConvention Exhibitor Hall

There’s still time to meet with the companies.  Below are some highlights to give you a taste of the cutting-edge technology that was presented:

PhylloTech developed a method to produce large amounts of protein from tobocca plants that is not only cost efficient but environmentally safe compared to traditional methods.  

Privo Technologies developed a topical wafer for the treatment of oral cancer.

Humanetics developed an oral suspension pill that patients can take to protect them from the harmful effects of radiation therapy and diagnostic procedures.

Kiyatec developed a 3-D cell-based phenotypic models of cancer to allow for better testing of therapeutics targets.

Novasentis developed the world’s first digitally controlled catheter.

CytoVale developed a rapid label-free diagnostic platform to clinically validate hundreds of patient samples with 85% sensitivity and specificity.

Sharklet developed the worlds first texture designed to inhibit bacterial contamination.  This is predominantly useful for tubing sets used in hospital settings where bacterial infections contribute to 10,000 deaths a year.

Phi Optics developed a label-free, non-invasive quantitative live cell imagining.

Image 2: Daniel Pfaff (left) and Danielle M. Stacy, PhD (right) present their company, PhylloTech, at #BIO2014 Innovation Zone.

Image 2: Daniel Pfaff (left) and Danielle M. Stacy, PhD (right) present their company, PhylloTech, at #BIO2014 Innovation Zone.

SDBN Blog »

Future of Cancer Therapeutics: #BIO2014

June 25, 2014 – 7:29 am | Edit Post

It has been four decades since the initiation of President Nixon’s “War on Cancer”, but never have the signs for victory looked so encouraging. This is an exciting phase in cancer research, so much so that some in the field are even using the “c” word. Cure!

via Future of Cancer Therapeutics: BIO2014.

SDBN Blog »

Bioethics in Drug Development: BIO2014

June 24, 2014 – 6:52 am | Edit Post

Consider a case where a patient has a disease with high mortality and no effective treatment available. A new experimental drug is now being tested in a clinical trial. However, this is a randomized clinical trial, which means that it will have a treatment group and a placebo group (that does not get the actual drug).

via Bioethics in Drug Development: BIO2014.

Latest News

Isis heart drugs get good news

September 2, 2014 – 2:06 pm | Edit Post

Carlsbad biotech Isis announces progress with two of its flagship heart drugs.

Enzyme Controlling Metastasis of Breast Cancer Identified

September 2, 2014 – 12:18 pm | Edit Post
Enzyme Controlling Metastasis of Breast Cancer Identified

Researchers at the University of California, San Diego School of Medicine have identified an enzyme that controls the spread of breast cancer. The findings, reported in the current issue of PNAS, offer hope for the leading cause of breas…

The Daily Aztec : SDSU researchers bring sea-quencer aboard

September 2, 2014 – 9:54 am | Edit Post

The Daily Aztec : SDSU researchers bring sea-quencer aboard.

Which Countries Excel in Creating New Drugs? It’s Complicated

September 2, 2014 – 12:00 am | Edit Post
Which Countries Excel in Creating New Drugs? It’s Complicated

A lot has been written lately about innovation, or the lack thereof, in the world of biopharma. One question that often gets asked: which countries lead the way in creating new medicines? Many people…

[[Click headline to continue reading.]]

Latest Jobs

Production Chemist (San Diego)

September 2, 2014 – 5:47 pm | Edit Post

Looking for a new and exciting opportunity for a medical device company in San Diego?
Title: Production Chemist
This position will be directly involved with the processing of particle chemistries in a GMP environment. This role requires that batch […

Sr. Software Quality Engineer at Simply Biotech (San Diego, CA)

September 2, 2014 – 4:48 pm | Edit Post

Biotech specializes in recruiting exclusively for the biotech community. We are currently seeking a Sr. Software Quality Engineer for a leading and growing biotech firm located in San Diego, CA. To ensure quality application systems…

Software Quality Assurance Engineer at Simply Biotech (San Diego, CA)

September 2, 2014 – 4:48 pm | Edit Post

Biotech specializes in recruiting exclusively for the biotech community. We are currently seeking a Software … Quality Assurance Engineer for a leading and growing biotech firm located in San Diego, CA. To ensure quality…

Immunotherapy Sales Specialist (San Diego, CA) – Dendreon Corporation – San Diego, CA

September 2, 2014 – 4:27 pm | Edit Post

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization…
From Dendreon Corporation – 02 Sep 2014 23:27:07 GMT
– View all …